Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigens

Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigens

US Patent 12161724 · Granted Dec 10, 2024

Estimated economic value: $191,980,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods related to tumor activated antibodies targeting EGFR an2025
Compositions and methods related to tumor activated antibodies targeting EGFR an2025
Compositions and methods related to tumor activated antibodies targeting EGFR an2025
Transglutaminase 2 (TG2) inhibitors2024
Compositions and methods related to tumor activated antibodies targeting PSMA an2023
Compositions and methods related to tumor activated antibodies targeting PSMA an2023
Transglutaminase 2 (TG2) inhibitors2023
Cleavable linker compositions and methods2022
Cleavable linker compositions and methods2022
Method of using a bispecific antibody to conditionally inhibit a receptor signal2021
ACVR2A-specific antibody and method of treatment of muscle atrophy2021
Antigen binding molecules to TIGIT2020